News
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
In PAH, 5-year mortality is similar with and without obesity, even though patients with obesity have more comorbidities and worse functional capacity.
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
The 85th American Diabetes Association Scientific Sessions have shown the depth of China’s play for the GLP-1 market, with ...
Obesity caused by a high-fat Western diet damages the pancreas, affecting insulin production and blood sugar control even ...
Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback